| - GRCh37:
- Chr10:124269618
- GRCh38:
- Chr10:122510102
| HTRA1 | A376V | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Uncertain significance (Nov 24, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr10:124221343-124221346
- GRCh38:
- Chr10:122461827-122461830
| ARMS2, HTRA1 | R59fs | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Pathogenic (Dec 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124249035
- GRCh38:
- Chr10:122489519
| HTRA1 | N224fs | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Likely pathogenic (Sep 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124266286
- GRCh38:
- Chr10:122506770
| HTRA1 | F286S | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Uncertain significance (May 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124266402
- GRCh38:
- Chr10:122506886
| HTRA1 | | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Likely pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124221451
- GRCh38:
- Chr10:122461935
| HTRA1 | V95L | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Uncertain significance (Jun 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124266249
- GRCh38:
- Chr10:122506733
| HTRA1 | R274W | Inborn genetic diseases, not provided, Age related macular degeneration 7, CARASIL syndrome, Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Uncertain significance (Nov 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:124248955
- GRCh38:
- Chr10:122489439
| HTRA1 | R197Q | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Uncertain significance (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124266334
- GRCh38:
- Chr10:122506818
| HTRA1 | R302Q | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, CARASIL syndrome, not provided
| Pathogenic/Likely pathogenic (Aug 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:124248441
- GRCh38:
- Chr10:122488925
| HTRA1 | R166C | not provided, Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Pathogenic/Likely pathogenic (Oct 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:124266896
- GRCh38:
- Chr10:122507380
| HTRA1 | S328L | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Uncertain significance (Aug 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124273671
- GRCh38:
- Chr10:122514155
| HTRA1 | | CARASIL syndrome, Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not provided
| Benign (Aug 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:124266249
- GRCh38:
- Chr10:122506733
| HTRA1 | R274G | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Likely pathogenic (Jul 22, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr10:124266264
- GRCh38:
- Chr10:122506748
| HTRA1 | V279M | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not provided | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:124221306
- GRCh38:
- Chr10:122461790
| HTRA1 | C46* | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Uncertain significance (Oct 22, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124266400
- GRCh38:
- Chr10:122506884
| HTRA1 | N324T | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Likely pathogenic (Apr 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124266294
- GRCh38:
- Chr10:122506778
| HTRA1 | Q289* | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not provided | Pathogenic (Nov 3, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:124266256
- GRCh38:
- Chr10:122506740
| HTRA1 | G276A | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Likely pathogenic (Apr 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124249132
- GRCh38:
- Chr10:122489616
| HTRA1 | I256T | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Pathogenic (Apr 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124248488
- GRCh38:
- Chr10:122488972
| HTRA1 | A182fs | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not provided | Pathogenic (Dec 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:124248481
- GRCh38:
- Chr10:122488965
| HTRA1 | I179N | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Likely pathogenic (Apr 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124221527
- GRCh38:
- Chr10:122462011
| HTRA1 | G120D | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Likely pathogenic (Apr 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124271595
- GRCh38:
- Chr10:122512079
| HTRA1 | | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not provided, Macular degeneration, CARASIL syndrome | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:124271589
- GRCh38:
- Chr10:122512073
| HTRA1 | | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not provided, Macular degeneration, CARASIL syndrome | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:124266885
- GRCh38:
- Chr10:122507369
| HTRA1 | | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Pathogenic (Sep 21, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr10:124266281
- GRCh38:
- Chr10:122506765
| HTRA1 | S284R | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Pathogenic (Sep 21, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr10:124248462
- GRCh38:
- Chr10:122488946
| HTRA1 | A173P | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Pathogenic (Sep 21, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr10:124248442
- GRCh38:
- Chr10:122488926
| HTRA1 | R166L | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | Pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:124266333
- GRCh38:
- Chr10:122506817
| HTRA1 | R302* | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, not provided | Pathogenic/Likely pathogenic (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |